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Abstract 
Escherichia coli hemolysin (HlyA) inserts into target membranes producing a cation-selective pore. We approached the problem of 
determining which portions of this protein remain exposed on the side of attack by applying specific antibodies. Results obtained with 
resealed erythrocyte ghosts and planar phospholipid membranes were compared. The effects of one polyclonal and four monoclonal 
anti-hemolysin antibodies (mAbs) were studied. Using ghosts we found one mAb which strongly reduced the ion-permeability through the 
preinserted HlyA channels and one which clearly increased it. Experiments with planar bilayers corroborated these results by showing that 
the former mAb effectively promoted the closed state of the channel whereas the latter forced the HIyA channel into an open 
configuration. Anti-hemolysin polyclonal antibodies initially stimulated but then prevented channel opening, indicating they contained 
clones able to act on both these channel determinants. They were effective only when applied on the same side as the hemolysin 
indicating that the epitopes were exposed to that side. Finally, the antigenic epitopes of three of the mAbs were localised on the HlyA 
molecule by using different mutants (amber and frame shift mutants and hemolysin gene hybrids). 
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1. Introduction 
Escherichia coli hemolysin (HlyA) is the prototype of a 
family of pore-forming cytotoxins elaborated by Gram- 
negative organisms including E. coli, Proteus, Mor- 
ganeIla, Pasteurella, Bordetella nd Actinobacillus species 
[1,2]. These toxins are secreted by a common, not yet fully 
understood, mechanism [3]. To become activated, they 
require a post-translational modification consisting of an 
Abbreviations: PC, phosphatidylcholine; PS,phosphatidylserine; RBC, 
red blood cells; TLC, thin-layer chromatography; PEG, poly(ethylene 
glycol); SPQ, 6-methoxy-N-(3-sulfopropyl)quinolinium; DIDS, diisothio- 
cyanostilbene-2,2'-disulfonic acid; HlyA, Escherichia coli hemolysin; 
mAb, monoclonal antibody; PLM, planar lipid membrane; ELISA, en- 
zyme-linked immunoadsorption assay. 
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acylation step [4,5]. A prominent feature of these toxins is 
the presence of regions containing homologous glycine-rich 
repeated nonapeptides, which have been found also in 
other non-toxic bacterial proteins, e.g., Pseudomonas, Ser- 
ratia and Erwinia proteinases [6-8] and Rhizobium nodu- 
lating protein NodO [9]. These repeats form short/3-strands 
organised in an unusual spring-like structure, called paral- 
lel /3-barrel or fl-superhelix, which binds Ca2+-ions in a 
stoichiometry of one ion per repeat [6]. It was suggested 
that Ca 2+ has a structural role in stabilising this peculiar 
folding [6], and Ca2+-ions were found to be necessary both 
for cell-binding and for expression of lytic activity by 
HIyA [10,11]. 
HlyA has a wide spectrum of cytocidal activity attack- 
ing granulocytes [12,13], monocytes [14], endothelial cells 
[15], and renal epithelial cells [16]. The leukocidal action 
of other members of this toxin family has also been 
documented (reviewed in [1,2]). Basic functional aspects 
of the family have been most thoroughly investigated with 
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HlyA [17,18] and it was found that erythrocytes, and even 
planar lipid membranes (PLM), are valuable models for 
studying toxin action [19-22]. HIyA transmembrane pores 
have been sized to 1-2 nm functional diameter both in 
RBC and in PLM [19,23]. They display cation selectivity, 
voltage-and pH-dependence, and are sensitive to pro- 
teinases [19,24,25]. 
Once bound to a membrane HIyA behaves as an intrin- 
sic protein as it cannot be extracted from RBC membranes 
without the use of a detergent [23] and the pore formed in 
a PLM, either in the open or in the closed configuration, 
cannot be detached from the lipid film by thorough perfu- 
sion with toxin-free solution [26]. In a PLM the channel is 
disposed asymmetrically in the membrane because prote- 
olytic enzymes digest it only when applied to the cis side 
[19,24]. Similar results were obtained also in the case of 
HlyA-pores on RBC membranes [25], implying that the 
membrane bound configuration of HIyA might be similar 
in both natural and model membranes. 
In this work we have used different anti-HlyA antibod- 
ies to determine which portions of the toxin remain ex- 
posed to the cis side of the membrane after channel 
insertion into RBC and PLM. Stimulatory, inhibitory and 
indifferent monoclonal antibodies have been identified and 
the localisation of their epitopes was investigated. 
2. Materials and methods 
2.1. Chemicals 
HIyA was prepared as described [23], lyophilised and 
stored at -20°C. These preparations were stable for sev- 
eral months. Anti-HlyA polyclonal antibodies (IgG) were 
raised in rabbits and purified by affinity chromatography. 
Anti-HlyA mAbs were prepared as described [27]. The 
f luorescent  marker  6 -methoxy-N- (3 -  
sulfopropyl)quinolinium (SPQ) was purchased from Cal- 
biochem. Saturated egg phosphatidylcholine (PC) came 
from P.L. Biochemicals, brain phosphatidylserine (PS) was 
from Calbiochem. Both lipids were more than 99% pure 
by TLC. 
The following buffer solutions were used. Buffer PBS: 
NaCI 150 mM, sodium phosphate 5 mM, pH 8.0 (isotonic 
solution). Buffer 5P8: sodium phosphate 5 mM, pH 8.0 
(hypotonic solution). Buffer A: sucrose 100 mM, KC1 100 
mM, Hepes-Tris 50 mM, pH 7.0 (internal chloride solu- 
tion). Buffer B: sucrose 100 mM, K2SO 4 66 mM, Hepes- 
Tris 50 mM, pH 7.0 (external sulfate solution). Buffer C: 
KC1 100 mM, Hepes-Tris 5 mM, pH 7.0. 
2.2. Assays 
Determination of hemolytic activity 
After reconstitution i water, the hemolytic activity of 
HIyA was tested on human erythrocytes as described [23]. 
Briefly: samples of HlyA were serially diluted into a 96 
wells microtiter plate (each well contained 50 /,1 Buffer 
PBS and the toxin was twofold-diluted at each step). An 
equal volume of human RBC (2.5% (v/v)  in Buffer PBS) 
was added to the wells and titers were read visually after 
one hour incubation at 37°C and expressed as the recipro- 
cal of the last dilution giving > 50% hemolysis. Hemolytic 
activity was usually around 1000-2000 hemolytic units/ml 
(HU/ml). Under these conditions we found that the rela- 
tion between hemolytic activity and molar concentration of
HlyA, as it was calculated from its UV absorption using an 
extinction coefficient e280 of 73 960 M-  1 cm- 1 (evaluated 
from the primary sequence) was 1 HU/ml  = 10 nM= 1 
/zg/ml. 
Preparation of SPQ loaded erythrocyte ghosts and assay 
of chloride / sulfate exchange 
Pink erythrocyte ghosts were resealed in the presence of 
4 mM SPQ by a procedure adapted from [28] that we 
extensively described earlier [25]. Thereafter, they were 
washed twice in cold Buffer A (10 min centrifugation at 
22000 × g), in order to remove untrapped SPQ. The final 
pellet had a count of about 3 - 109 ghost/ml and a protein 
content of 3.3 mg/ml  as determined by the method of 
Lowry [29]. It was resuspended in 3 volumes of Buffer A 
and kept on ice. 
C1-/SO42 exchange was measured using a Jasco 
FP550 spectrofluorimeter essentially as described [25]; ex- 
citation was set at 320 nm and emission at 445 nm. 
Briefly: 5 /xl of SPQ-loaded ghosts were added to a quartz 
cuvette containing 1 ml of the sulfate buffer (Buffer B) at 
25°C. The release of chloride from the interior of the 
ghosts (in exchange with sulfate) resulted in an increase of 
SPQ fluorescence since the chloride-induced quenching 
was removed [30]. Maximal SPQ fluorescence was deter- 
mined each time by addition of 1 mM Triton X-100 and 
used as 100%. 
Binding of monoclonal antibodies to HlyA-permeabilized 
RBC 
Toxin-treated erythrocyte membranes were prepared 
mixing rabbit erythrocytes (10 9 cells per ml in PBS) with 
HlyA (final concentration 1000 HU/ml)  and incubating 
for 1 h at 37°C. Pelleted cells and membranes were washed 
twice in PBS (16000 × g, 10 min), and thrice in Buffer 
5P8 (which converted even unlysed cells to ghosts). In 
controls, toxin was omitted and cells were lysed simply by 
exposure to the hypotonic buffer. The final pellet was 
resuspended in PBS (original volume) and 500/zl aliquots 
were transferred to Eppendorf tubes for ELISA measure- 
ments. Prior to use, the walls of these tubes were blocked 
with 0.5% gelatin in PBS. Purified mAbs in PBS were 
added to each tube (final concentration: 10 /xg/ml) and 
incubated for 60 min at 37°C. The membranes were washed 
thrice in PBS plus 0.5% gelatin. Binding of mAb was 
detected incubating with a second antibody (rabbit anti- 
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mouse-IgG alkaline phosphatase conjugated, Dakopatts, 
Hamburg, diluted 1:1000 in PBS) in a total volume of 500 
/~l/tube for 45 min at 37°C. Thereafter, a substrate (p- 
nitrophenylphosphate; Sigma, Munich, Germany) was 
added for approx. 5 min and the enzyme reaction was 
stopped by spinning the membranes down; the colour 
development in the supernatant was read photometrically 
at 405 nm (SLT Labinstruments, Overath, Germany). 
Antibody effects on HlyA-permeabilized ghosts 
Ghosts were resealed in the presence of 4 mM SPQ as 
described above (1 h incubation at 37°C). Before removing 
the untrapped fluorophore, they were further incubated 15 
min with HlyA at 37°C. Unbound toxin was removed by 
washing three times (10 min, 14000 X g) in Buffer A 
containing 4 mM SPQ. After this step a sample of the 
HlyA-treated ghosts was used as control, the rest was 
subjected to incubation with the antibodies for 30 min 
(room temperature). Unbound antibodies and untrapped 
SPQ were finally removed by washing twice and resus- 
pending in Buffer A. Compared to the starting sample of 
unsealed ghosts, the final pellet was tenfold concentrated. 
During this procedure all the buffer solutions were supple- 
mented with 3 mM PEG (Fluka, M r 6000) to prevent ghost 
swelling [25]. The amount of SPQ retained was estimated 
by mixing 5 /~1 of ghosts with 1 ml of Buffer B in a 
cuvette and following the time-course of the fluorescence 
increase in a fluorimeter as described above. Further con- 
trois were prepared either omitting the toxin or adding first 
polyclonal antibodies and then HIyA. 
Experiments with planar lipid membranes (PLM) 
PLM were prepared by apposition of two lipid mono- 
layers on a hole (0.2 mm in diameter) punched in a 12 /xm 
thick Teflon septum separating two 4 ml chambers con- 
taining Buffer C, essentially as described [24]. The hole 
was pretreated with n-hexadecane and the monolayers 
were spread from a 10 mg/ml lipid mixture (PC/PS in a 
1:1 molar ratio) dissolved in n-hexane. HIyA was added 
only on one side of a preformed stable bilayer (called the 
cis compartment). Membrane current, under voltage clamp 
conditions, was converted to voltage by a virtual grounded 
operational amplifier (Burr Brown OPA 104C). The cis 
compartment was connected to the virtual ground and 
voltage signs referred to it. Current is defined positive 
when cations flow into this compartment. The baseline 
conductance of these membranes was never larger than 50 
pS. Ag-AgCI electrodes, directly immersed into the elec- 
trolyte solution, were used. Experiments were performed at 
room temperature. 
Localisation of anti-HlyA mAb epitopes 
The localisation of the anti-HlyA epitopes recognised 
by the four mAbs was determined as previously described, 
i.e., by immunoblotting using the antibodies as probes 
against various HlyA recombinant s rains [31]. In addition 
to the recombinant s rains used in that earlier study, sev- 
eral new deletion mutants of HIyA [32] and hybrid genes 
composed of hlyA and the Pasteurella haemolytica leuko- 
toxin (IktA) [33] were employed. None of the anti-HlyA 
mAbs used here cross reacted to LktA. Therefore, we 
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Fig. 1. Anion exchange through uman resealed erythrocyte ghosts before and after exposure to E. coli hemolysin. At time zero 5 /xl of SPQ-loaded 
resealed ghosts, washed in chloride buffer (Buffer A) were added to a cuvette containing 1ml of sulfate buffer (Buffer B). The final protein concentration 
was 5.5 /zg/ml. Chloride release from the interior of the ghosts (in exchange with sulfate) resulted in an increase of the fluorescence as the 
chloride-induced quenching of the internal fluorophore was relieved [30]. Reported is the time course of the fluorescence increase F - F o (where F and Fo 
are the fluorescence at time t and time zero, respectively) normalized by dividing by its maximal value, obtained with 1 mM Triton X-100 (F= - Fo). 
Lower trace was in the presence of 2 p,M DIDS which almost abrogated the exchange. (The dependence of the initial rate of exchange on the external 
concentration f sulfate is shown in (B).) At the position indicated by the arrows, different doses of HlyA were added to the cuvette (2, 4 and 8 HU/ml, 
from bottom to top, in the upper three traces). The sustained fluorescence increase was due to the formation of pores into the resealed membranes and was 
unaffected by DIDS (lower trace, 8 HU/ml). (The initial rate of HlyA-induced release is shown in (C) to depend linearly on the toxin concentration.) The 
final addition of 1 mM Triton X-100, to obtain 100% SPQ dequenching, is indicated by an open arrow-head. 
100 assumed that the reactivity of a test mAb to a LktA-HlyA 
hybrid protein localised the mAb epitope to the portion of 
HlyA present in that hybrid. 
3. Results and discussion 
3.1. HlyA-induced opening of pores in resealed ghosts 
When resealed erythrocyte ghosts, loaded with SPQ and 
its quencher chloride, were transferred to a sulfate solution 
the fluorescence of the internally entrapped SPQ gradually 
increased with time (Fig. 1A). This was due to the ex- 
change of internal chloride with external sulfate promoted 
by the band 3 protein [25]. In fact, the release was blocked 
by DIDS, a well known inhibitor of the RBC anion 
exchanger [34], and its rate was proportional to the exter- 
nal concentration f sulfate (Fig. I B). 
If HIyA was added to the resealed ghosts, after their 
transfer to the sulfate solution, a larger and faster increase 
of the fluorescence appeared immediately and proceeded 
to a steady state at which Triton X-100 did not produce 
much more fluorescence increase (Fig. IA). This effect 
was independent of the band 3 protein (it was not affected 
by DIDS) and its rate was proportional to the concentra- 
tion of HIyA added (Fig. 1C). Hence, it could be attributed 
to the formation of toxin-induced ion channels into the 
ghost membrane, in analogy to the case of RBC and model 
membranes [19,23,35]. 
Polyclonal anti-HlyA antibodies were able to counteract 
this effect in a dose dependent manner (Fig. 2). Two 
mechanisms may concur to produce the inhibitory effect 
shown: the antibody may prevent oxin binding, or they 
may prevent transport hrough the toxin pores. In the 
following we will try to discriminate between these two 
possibilities. 
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Fig, 3. Capacity of resealed erythrocytes xposed to HlyA to retain SPQ. 
Ghosts resealed in the presence of 4 mM SPQ were incubated 15 min 
with different concentrations of HIyA at 37°C and then washed thrice in 
Buffer A. The amount of SPQ retained was determined by mixing 5/zl of 
ghosts with 1 ml of Buffer B and following the time-course of the 
fluorescence increase as in Fig. l. 100% corresponds to controls where 
the toxin was omitted. Solid line was drawn by eye. 
3.2. Effects of anti-HlyA antibodies on preformed pores 
Resealed ghosts 
HIyA pores were large enough to permit efflux of SPQ 
out of the ghosts. In fact, if erythrocyte ghosts resealed in 
the presence of SPQ were incubated with increasing con- 
centrations of HIyA, before removing the external fluo- 
rophore, they became progressively unable to retain SPQ 
(Fig. 3). We found that at 8 HU/ml each ghost carried 
enough HlyA-induced pores to be completely leaky to the 
fluorescent molecule. This is not surprising, since SPQ is a 
cation and has a molecular weight of 300 Da which is well 
below the predicted cut-off of the HlyA channel (around 
2000 Da [23]). 
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Fig. 2. Effects of polyclonal anti-HlyA antibodies on the rate of ghost permeabilisation by HlyA. (A) Same as Fig. 1 except hat soon after addition of 
HlyA (8 HU/ml),  different doses of anti-HlyA polyclonal antibodies were added to the cuvette (where indicated by the arrow-head). (The initial rate of 
HlyA-induced release is shown in (B) to be inversely related to the antibody concentration.) Also in this case, 100% SPQ dequenching was obtained 
adding 1 mM Triton X-100 (indicated by an open arrow-head). Other experimental conditions as in Fig. l. 
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Interestingly, this procedure appeared to be suited to 
estimate the number of open channels present in the 
ghosts. Using this approach we then investigated the ef- 
fects of monoclonal and polyclonal anti-HlyA antibodies 
on preformed pores (Fig. 4). After incubation with the 
toxin the ghosts were washed (in the presence of SPQ) and 
further incubated with the antibodies. Finally, external 
SPQ was removed and the amount of SPQ retained was 
determined. 
Polyclonal antibodies did not reduce significantly the 
membrane permeability mediated by preformed HIyA pores 
(Fig. 4B), although they were able to protect he ghosts 
almost completely if added before the incubation with the 
toxin (which is consistent with the results in Fig. 2), and to 
prevent RBC hemolysis (not shown). 
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Four anti-HlyA mAbs were then tested. Although none 
of these mAb could protect RBC from hemolysis, they all 
bound to washed membranes of HlyA-lysed RBC (Fig. 
4A). When tested for their effect on preformed pores, they 
behaved differently (Fig. 4B). The clearest effect was 
obtained with mAbs f11F and llC. The former inhibited 
permeability whereas the latter promoted it. Of the other 
two, h2A had almost no effect, whereas h11A had a 
protective ffect similar, albeit less pronounced, to that of 
f l lF.  
Planar lipid membranes 
These effects could be understood in more detail by 
using a simplified membrane model such as the planar 
lipid membrane. In these membranes HlyA forms ionic 
channels which are open most of the time at negative 
voltages but may be closed by application of a positive 
voltage [19,24]. None of the four mAbs could prevent he 
formation of pores in the bilayer even if preincubated with 
HIyA. Nonetheless when applied to preformed HIyA pores 
they produced distinct effects. The clearest effect was 
again obtained with mAbs f l l F  and llC. MAb f l l F  led 
to closing of the preformed channels either at negative or 
at positive applied voltages (Fig. 5A), whereas mAb llC 
promoted further opening of HlyA pores at negative volt- 
ages (Fig. 5B). Both of the other two mAbs, h2A and 
hllA, had very little effect (Fig. 4C). 
These results, consistent with those obtained using re- 
sealed ghosts, indicated that the protective ffect of mAb 
f l l F  was due to the fact that its binding to the HlyA pores 
either closes the pores by steric hindrances or increases 
their probability to be in the closed state independently of 
the applied voltage. Similarly the permeability-stimulating 
Fig. 4. Interaction of four different anti-HlyA monoclonal antibodies 
(f11F, h2A, hllA, llC) with membrane bound HIyA. (A) ELISA quanti- 
tation of the binding of the mAbs to HlyA-hemolysed RBC membranes 
(shaded bars). Full bars represent a control experiment in which hypotoni- 
cally-lysed RBC membranes were incubated with all four the anti-body 
clones at the same time. a4C1 was a second control experiment in which 
HlyA-lysed RBC membranes were incubated with a mAb directed against 
a-toxin of S. aureus. The ELISA was developed with a second antibody 
against mouse IgG (alkaline phosphatase conjugated) and absorbance was 
read at 405 nm. (B) Relative amount of SPQ retained in the internal 
compartment of ghosts exposed (before removing the untrapped fluo- 
rophore) to 2 HU/ml  of hemolysin for 15 min at 37°C, full bars, or to the 
same amount of toxin followed by 0.3 mg/ml  monoclonal or 0.06 
mg/ml  polyclonal antibodies (after removing the unbound toxin) for 30 
rain at room temperature, shaded bars. The amount of SPQ retained was 
calculated as in Fig. 3. 100% was given by control experiments with no 
toxin and no antibody added. Empty bar was for ghost incubated with 
polycional anti-HlyA antibodies before adding the toxin. (C) Relative 
amount of HlyA-channels which were found open at steady state in a 
planar lipid membrane clamped at -20  mV after exposure to 10 HU/ml  
of hemolysin (full bars = 100%) or to the same amount of toxin followed 
by 0.025 mg/ml  monoclonal or 0.01 mg/ml  potyclonal antibodies for 30 
min (shaded bars). Empty bar was the effect of preincubating HIyA with 
polyclonal antibodies. Other experimental conditions as in Fig. 5. 
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Fig. 5. Effects of different anti-HlyA antibodies on HlyA-pores present in 
a planar lipid membrane. A stable PC/PS PLM was incubated with 10 
HU/ml HIyA (added only to the cis compartment). Ionic channels were 
soon formed into the lipid film whose opening and closing properties 
were determined by the applied voltage. Open arrow heads indicate 
switching the clamp voltage from -20 mV to +40 mV, closed arrow 
heads indicate switching from + 40 mV to - 20 mV. After the transition 
to the negative voltage the pores slowly open to reach a steady state. 
Immediately after the transition to the positive voltage the pores are open, 
but then they close very quickly and almost completely, as indicated by 
the vertical decay of the current. Where indicated 0.025 mg/ml of 
different antibodies were added to the cis compartment which was 
continuously stirred. (A) MAb f l lF  induced the closure or block of 
preformed HIyA channels even at a negative applied voltage which 
usually keeps the channels open. However, fllF-induced blockage was 
faster when the channels were previously brought into the closed state by 
a positive voltage: note that after the very short transition to +40 mV 
(denoted with an asterisk) quite a few channels were able to reopen at the 
negative voltage. (B) MAb 1C promoted further opening of HlyA pores 
at negative voltages but did not prevent heir voltage-induced closing at 
+40 mV. (C) Polyclonal antibodies (despite being fully protective if 
preincubated with the toxin) induced a complex effect which may be 
regarded as the sum of the two effects shown in (A) and (B). They first 
stimulated new opening of pores but then induced closing of the channels. 
They failed to produce any effect when applied on the trans side (not 
shown). In each panel the dashed line indicates zero current. Experiments 
were performed at room temperature. 
effect of  mAb l lC  could be attributed to its ability to 
promote the permanence of HIyA channels in the open 
state. 
Polyclonal antibodies were strongly protective if  prein- 
cubated with the toxin (Fig. 4C), but induced a complex 
effect when applied to preformed pores (Fig. 5). This 
effect may be regarded as the sum of those observed with 
mAb f11F and llC. They first stimulated new opening of  
pores, but then induced a closing of  the channels (Fig. 5C). 
This result suggested that the polyclonal antibody may 
contain clones able to bind to both the structural determi- 
nants responsible for the closing and opening effect of  
mAbs f l l F  and l lC  respectively. When applied to the 
trans side of  the membrane (i.e., opposite to the toxin) the 
polyclonal antibody did not produce any effect, indicating 
that the epitopes are only exposed to the cis side. 
3.3. Mapping the anti-HlyA mAb epitopes 
We then tried to localise the epitopes of  the four mAbs 
on HIyA using the procedure described in [31], i.e., im- 
munoblott ing against different H lyA mutants, as listed in 
Table 1. We found that these epitopes were all independent 
of  the HIyC modif ication of  HlyA, since both activated 
and non-activated HlyA reacted in all cases (not shown). 
Their precise localisation however, was not without prob- 
lems (Fig. 6). Ideally, an epitope is localised by the 
retention of  the reactivity of  the corresponding mAb to 
smaller and smaller peptide fragments. Yet, with these four 
mAbs, we often observed that reactivity was lost in some 
Table 1 
HIyA derivates used for localisation of mAb epitopes by immunoblotting 
Strain Number Portion Notes Ref. 
for of HIyA 
Fig. 6 present 
WAM589 - 1-1023 (a) 
WAM783 - 1-1023 (b) [31] 
WAM619 1 1-829 (c) [31] 
WAM676 2 1-726 (c) [31] 
WAM841 3 161 - 1023 (d) [31 ] 
WAM802 4 626-1023 (d) [31] 
WAM713 5 1-726, 829-1023 (e) [31,32] 
WAM1233 6 1-672, 746-1023 (e) [31,32] 
WAM1263 7 1-625, 674-1023 (e) [31,32] 
WAM 1127 8 392-1023 (f) [33] 
WAM1161 9 1-391 (g) [33] 
WAM1043 10 564-1023 (f) [33] 
WAM1046 11 1-563 (g) [33] 
WAM 1025 12 740-1023 (f) [33] 
WAM1022 13 1-739 (g) [33] 
a HlyA wild type. 
b HIyA synthesised in the absence of HIyC activation. 
HIyA frameshift mutants. 
d Hlya secreted C-terminal fragments. 
e HlyA inframe deletion mutants. 
f LktA/HIyA hybrids. 
g HlyA/LktA hybrids. 
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mutant forms that independent evidence indicated should 
retain the epitope. 
The epitope for f l l F  must reside in the carboxy-termi- 
nal 40 kDa HlyA fragments because it reacts to the 
WAM802 secreted form of HIyA. In addition, because this 
mAb reacts to the LktAl_732-HlyA740_]023 hybrid, the 
epitope appears to reside in the HIyA glycine-rich repeat 
region or further toward the C-terminus. The problem is 
how to interpret the lack of reactivity of this mAb to either 
the HIyA-Bgl I I  frameshift (HlyA~_8: 9) or the inframe 
HlyA deletion lacking residues 726-829.  The f11F  epi- 
tope may actually reside in HlyA 829_1023 region and the 
inframe deletion lacking most of the repeats folds unusu- 
ally to obscure its epitope. Alternatively, the epitope may 
have a structure made of discontinuous elements involving 
the repeats and C-terminal portion of the molecule, or it 
may very well be a continuous epitope around the HlyA829 
position with portions of it missing both in the frameshift 
and inframe mutants. Lastly, although the size of the HIyA 
fragments reported in Table 1 was consistent with their 
molecular weight as determined by SDS-PAGE, because 
of the limited precision of this method we cannot exclude 
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Fig. 6. Mapping of the four mAbs' epitopes. (A) Reactivity of the mabs to different HIyA mutants (numbered 1 to 13 as listed in Table 1), was studied by 
immunoblotting. Dashed bars represent constructs which positively reacted to a given mAb, empty bars those that were negative. Note that only the HlyA 
part of the molecule was reported in the case of HlyA-LktA hybrids. Ideally each mAb is mapped to a region which intercepts all positive bars and no 
negative one, however this was never possible. Dashed boxes indicate the most probable pitope location, i.e., a region containing all positive and at most 
one negative construct. All mAbs reacted to WAM 589 and WAM 783, i.e., acylated and non-acylated mature HlyA. (B) Average antigenicity calculated 
using the chain-flexibility scale introduced by Karplus and Schulz [36], (with a 21 AA window). The scale is based on the individual temperature factors of 
the C 2 atoms of AA belonging to a database of 31 proteins of known three dimensional structure. Most antigenic stretches are those exceeding the dashed 
line, which represents he sum of the average flexibility plus its S.D. (C) Location of some structural features along the HlyA molecule: open and closed 
bars, represent hydrophobic and amphipathic a-helices, respectively [20]; shaded bars, three groups of glycine-rich repeats [44]; asterisks, positions at 
which the mature molecule is acylated [5]. 
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the possibility of undetected protease processing of short 
segments at their termini. Taking all this into account, the 
most conservative interpretation of the f l l F  blotting data 
would put its epitope within the HiyA740_~023 region. 
In the case of hllA, the reactivity to the WAM1025 
LktAl_732-HlyA732_1023 hybrid indicates its epitope lies 
between HlyA740_1023. The retention of reactivity to the 
HIyA deletion lacking position 727 through 828 indicates 
that the epitope lies in the HlyA 829_1023 region. The 
irregularity to the reactivity of h11A is its failure to bind 
in immunoblots to the 40 kDa carboxy-terminal fragment 
secreted by WAM802. 
The epitope for h2A lies either in the HlyA564_6:z5 or 
HIyA673_726 regions. It reacts to the WAM676 frameshift 
mutant covering residues 1-726 and to the WAM1043 
LktA 1 554-HlyA564_1023 hybrid. It also reacts to the 
WAMI263 deletion which lacks amino acids 626 through 
673. Therefore, its epitope is most likely to reside on either 
side of the deletion but not between position 1 through 563 
or 726 through to 1023. 
The most problematic was the llC mAb which reacted 
to just three of the different HIyA forms: wild-type HIyA 
(activated or not) and one deletion mutant lacking eleven 
of the thirteen glycine-rich repeats. Because this mAb does 
readily react to native HIyA by ELISA (Fig. 4A), these 
results suggest hat the llC epitope is likely to involve a 
discontinuous epitope that is not dependent on the glycine 
rich repeats or the HIyC acylation of HlyA, but which is 
sensitive to deletions or substitutions throughout the HlyA 
molecule. 
The results of mapping were compared to a theoretical 
profile of the average antigenicity along the hemolysin 
sequence obtained by the method of Karpplus and Schulz 
[36] (Fig. 6B). It appears that the two inhibitory mAbs 
( f l l F  and hllA) may in fact both bind to the repeat 
region which is the most antigenic. This region (Fig. 6C) is 
not believed to be itself part of the HIyA pore, which is 
instead most probably formed by a number of hydrophobic 
and amphiphilic a-helices which are grouped in the region 
from residue 100 through residue 412 [20] (a region highly 
conserved among the parent leukotoxins and known to be 
essential for the lytic, albeit not for the binding step 
[37,38]). Apparently, deletion of the repeats leaves unaf- 
fected the pore-forming ability of HlyA [11], however, it is 
still possible that binding of a mAb to this region causes a 
conformational change of the molecule such that the pore 
becomes blocked [39-41]. This is in line with the finding 
that a mutated hemolysin, with an insertion into the repeat 
region, is unable to form stable pores (G. Menestrina nd 
R. Welch, unpublished results). It also provides an expla- 
nation for the blocking effect of Zn 2+ [42] which can 
replace Ca 2+ in at least one binding site on the repeat 
region [6,43] and thus elicit a conformational change of the 
molecule. In any case our results would indicate that this 
region remains located cis, i.e., on the same side from 
which the toxin has approached the membrane. 
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